baber/WOPTO huggingface dataset:
Patent NZ-531771-A (NZ)
Title: Fuel cell adapter system for combustion tools
Inventor: ROBINSON JAMES W
IPC: F23K5/00
Filed: 2004-03-16
Abstract: An insert seal (44) for an adapter (16) connectable to a fuel cell (14) which is engageable upon a combustion tool fuel metering valve (12), the fuel cell having a stem (52) and the metering valve having a nipple (56), includes a body (46) defining a central passageway (48) and having a first end (50) sealable on the stem and a second end (54) sealable on the nipple, a flange portion (58) affixed to the second end, being in fluid communication with the passageway and having a larger diameter than the body. The fuel cell adapter (16) is configured for connection to the fuel cell and is engageable upon the combustion tool fuel metering valve, has an adapter body (18) with a base (22) configured for engagement upon the fuel cell and a nozzle (20) connected to the base, the adapter body defining a chamber (26) configured for accommodating the stem and the nipple, the insert seal (44) being accommodated in the chamber (26).
Patent NZ-534699-A (NZ)
Title: Glycoisoforms of adiponectin and uses thereof
Inventor: COOPER GARTH JAMES SMITH
IPC: G01N33/68
Filed: 2003-01-17
Abstract: Disclosed are glycosylated adiponectin polypeptides for the treatment of a range of conditions. Related compositions, uses and methods are also disclosed.
Patent NZ-534887-A (NZ)
Title: Gastric therapies and compositions therefor
Inventor: ROBERTSON ANTHONY MORRIS
Filed: 2004-08-23
Abstract: A composition and use thereof in the manufacture of a medicament for treatment of gastric and/or duodenal H.pylori infections, comprising a proton pump inhibitor in a systemically available dosage form, a mucolytic preparation, a proton pump inhibitor in a gastrically available dosage form and a fatty acid and/or monoglyceride.
Patent NZ-535983-A (NZ)
Title: Method for controlling microbending induced attenuation losses in an optical fiber
Inventor: ROBA GIACOMO STEFANO
IPC: C03C25/1065
Filed: 2002-04-24
Abstract: A method for controlling attenuation losses caused by micro-bending on the signal transmitted by an optical fiber having an internal glass portion (101) is disclosed. The internal glass portion (101) is provided with a first coating layer (102) of a first polymeric material to surround the glass portion and a second coating layer (103) of a second polymeric material to surround the first coating layer. The first polymeric material (102) has a hardening temperature lower than -10º C and an equilibrium tensile modulus lower than 1.3 MPa.
Patent NZ-536846-A (NZ)
Title: Fire proof treatment solution and fire retardant material therefrom
Inventor: ASANO NARIAKI
IPC: C09K21/04
Filed: 2003-05-30
Abstract: A fire retardant treatment solution produced by adding phosphoric acid and a silane coupling agent to a weak acid or weak alkali aqueous metal salt solution containing a boron compound to thereby obtain a mixed aqueous solution and adding a plant extract composed mainly of a polyphenolic compound to the mixed aqueous solution is disclosed; wherein this fire proof treatment solution is capable of resolving problems, such as low solubility leading to low concentration and hence low combustion inhibiting effect and water solubility leading to a disadvantage of eluviation, of boron compounds used as a constituent of flame retarding treatment solution; and wherein fire proof treatment solution can be widely applied to members composed mainly of cellulose, such as wood, paper and natural fibers. This fire proof treatment solution can increase the fixation of chemicals to thereby attain a high combustion inhibiting effect and can minimize the occurrence of eluviation.
Patent NZ-546620-A (NZ)
Title: Humanized antibodies that recognize beta amyloid peptide
Inventor: SCHENK DALE B
IPC: C07K16/00
Filed: 2006-04-18
Abstract: Improved agents and methods for treatment of diseases associated with amyloid deposits of Ass in the brain of a patient. Preferred agents include humanized antibodies.
Patent NZ-548674-A (NZ)
Title: Combination of oxine copper and a quaternary ammonium salt in an acid solubilised system
Inventor: FRAZER FRANK WILLIAM
Filed: 2006-07-21
Abstract: Disclosed is a biocidal composition consisting of at least: oxine copper, an acid or acids that at least in part solubilises the oxine copper, and at least one quaternary ammonium salt; wherein said at least one quaternary ammonium salt sufficient by itself, or said at least one quaternary ammonium salt is sufficient together with optional additives, to ensure the C10 corrosiveness (mg/L Fe) is less than 165.
Patent NZ-552514-A (NZ)
Title: Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it
Inventor: ROSENBERGER VERED
IPC: A61K9/22
Filed: 2002-11-12
Abstract: A toolset for producing a solid pharmaceutical dosage form comprising a core tablet sheathed in a compressed annular body of powder or granular material, the toolset comprising: a) a columnar punch having a protrusion, and b) a punch assembly comprising an annular punch and a core rod slidably engageable with the annulus of the annular punch, wherein the core rod is capable of movement between a retracted position and an extended position and wherein the core rod is biased in an extended position.
Patent NZ-554374-A (NZ)
Title: Diaminoalkane aspartic protease inhibitors
Inventor: BALDWIN JOHN J
IPC: A61K31/166
Filed: 2005-10-07
Abstract: Disclosed are diaminoalkanes of Formula I and IIB or enantiomers, diastereomers or salts thereof, wherein the substituents are defined within the specification. Also disclosed is the use of the said compounds in the manufacture of a medicament for antagonizing one or more aspartic proteases.
Patent NZ-561937-A (NZ)
Title: Processes for the preparation of azoxystrobin using 1,4-diazabicyclo[2.2.2]octane (DABCO) as a catalyst and novel intermediates used in the processes
Inventor: WHITTON ALAN JOHN
IPC: C07C69/734
Filed: 2006-04-13
Abstract: Disclosed is a process for the preparation of Azoxystrobin derivatives of formula (I), which comprises either (a) reacting a compound of formula (II) with 2-cyanophenol, or a salt thereof, in the presence of between 0.1 and 2 mol % of 1,4-diazabicyclo[2.2.2]octane, or (b) reacting a compound of the formula (III), with a compound or mixture of two compounds of the formula (IV) in the presence of between 0.1 and 2 mol % of 1,4-diazabicyclo[2.2.2]octane; where W is the methyl (E)-2-(3-methoxy)acrylate group C(CO2CH3)=CHOCH3 or the methyI 2-(3,3-dimethoxy)propanoate group C(CO2CH3)CH(OCH3)2.
Patent NZ-562090-A (NZ)
Title: X-ray backscatter detection imaging modules
Inventor: ADAMS WILLIAM
Filed: 2007-09-28
Abstract: An inspection system for inspection of an object by means of penetrating radiation comprises a. an imaging enclosure characterized by an enclosing body; b. a source of penetrating radiation contained entirely within the body of the imaging enclosure for generating a beam of penetrating radiation; and c. a detector module, contained entirely within the body of the imaging enclosure, for generating a signal based both upon penetrating radiation scattered by contents of the object and any penetrating radiation naturally emitted by the contents. (61) Addition to 539824
Patent NZ-563883-A (NZ)
Title: Oil suspension concentrate comprising dioxazine pyridylsulfonylureas
Inventor: SIXL FRANK
IPC: A01N25/04
Filed: 2006-05-13
Abstract: Disclosed herein is an oil suspension concentrate comprising a) one or more herbicidally active compounds from the group of the dioxazine pyridylsulfonylureas in suspended form, b) one or more organic solvents, and c) non-ionic emulsifiers and dispersants. Said oil suspension concentrate is suitable for use in the crop protection sector.
Patent NZ-566915-A (NZ)
Title: Generation and profiling of human derived therapeutic antibodies specific for human CD38
Inventor: TESAR MICHAEL
IPC: C07K16/28
Filed: 2006-10-12
Abstract: Disclosed are antibodies that are specific for CD38. The antibody comprises a heavy chain CDR1, CDR2 and CDR3 depicted in SEQ ID NO: 21, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103 or 105 and a light chain CDR1, CDR2 and CDR3 depicted in SEQ ID NO: 51. The antibody can comprise a heavy chain having SEQ ID NO: 21 and a light chain having SEQ ID NO: 51. The antibody can be used to treat a haematological disease selected from multiple myeloma, chronic lymphocytic leukaemia, chronic myelogenous leukaemia, acute myelogenous leukaemia and acute lymphocytic leukaemia. The antibody can also be used to treat an inflammatory condition selected from rheumatoid arthritis and systemic lupus erythematosus. The antibody can be used in a method for inducing specific killing of tumour cells by CD38 cross-linking.
Patent NZ-568971-A (NZ)
Title: Preparation of gamma-amino acids having affinity for the alpha-2-delta protein
Inventor: EVANS MARGARET CLAIRE
IPC: C07C227/32
Filed: 2006-12-11
Abstract: Disclosed are materials and methods for preparing optically active and gamma amino acids of Formula I which bind to the alpha-2-delta subunit of a calcium channel. These compounds, including their pharmaceutically acceptable salts, solvates and hydrates, are useful for treating vasomotor symptoms, restless legs syndrome, epilepsy and a variety of neurodegenerative, psychiatric and sleep disorders.
Patent NZ-570212-A (NZ)
Title: End-cap device for high efficiency disposable chromatography column
Inventor: DEORKAR NANDU
IPC: G01N30/60
Filed: 2007-01-04
Abstract: A disposable chromatography column is provided, which includes: a chromatography column body having an external wall and a hollow chamber through the body from an inlet end to an outlet end of the body, a shoulder adjacent the outlet end of the chromatography column body with a first fritted disk received on the shoulder, a flange extending radially outward from the inlet end of the chromatography column body, chromatographic media filling at least a portion of the chamber of the chromatography column body with a second fritted disk sitting on top of the chromatographic media furthest from the outlet end of the chromatography column body, a piston having an externally threaded upper portion, a lower portion smaller in diameter than the upper portion inserted into the inlet end of the chromatography column body, an annular recess on the lower portion of the piston with a sealing element located in the recess, a through-bore or conduit extending through the upper and lower portions of the piston for receiving and providing liquid to the second fritted disk and the chromatographic media in the chamber of the chromatography column body, and a retainer having first and second ends with an opening extending from the first end to the second end of the retainer, the opening at the first end sized to snugly slide over and engage the external wall of the chromatography column body, an annular shoulder between the first and second ends of the retainer and abutting the opening at the first end of the retainer, the annular shoulder receiving and supporting the annular flange extending from the chromatography column body, the opening having internal threads adjacent the opening at the second end of the retainer, the internal threads engaging the external threads of the piston whereby screwing the external threads of the piston into the internal threads of the retainer forces the lower portion of the piston and the annular sealing element against the second fritted disk in the chamber of the chromatography column body.
Patent NZ-572744-A (NZ)
Title: Process for making salts of n-hydroxy-3-[4-[[[2-(2-methyl-1h-indol-3-yl)ethyl]amino]methyl]phenyl]-2e-2-propenamide
Inventor: BAJWA JOGINDER S
IPC: C07D209/14
Filed: 2007-06-07
Abstract: Disclosed is a method of preparing the lactate monohydrate salt of N-hydroxy-3-[4- [[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide comprising the steps of: (a) suspending N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3 yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide free base monohydrate in acetone; (b) adding lactic acid dropwise with stirring at ambient temperature, wherein the lactic acid is present in an equimolar amount; (c) stirring the reaction mixture for a time sufficient to cause precipitation of the lactate monohydrate salt; and (d) cooling the reaction mixture.
Patent NZ-575316-A (NZ)
Title: Coke oven whrein one or more heating element are arranged in the gas chamber which is not filled with solid matter
Inventor: RONALD KIM
IPC: F27D99/00
Filed: 2007-09-07
Abstract: A non-recovery/heat recovery type coke oven (1) is disclosed. The coke oven (1) is of horizontal construction consisting of at least one coking chamber.(5) There are laterally arranged vertical downcomers (11)as well as bottom flues (8)arranged horizontally and underneath the coking chamber (5) for indirect reheating of the coking chamber (5). One or more heating element (12) is located in the gas chamber which is not filled with the solid matter when the coke oven (1) is appropriately used.
Patent NZ-575752-A (NZ)
Title: Navigation device with camera-info
Inventor: GEELAN PIETER ANDREAS
IPC: G01C21/34
Filed: 2005-06-06
Abstract: A navigation device is disclosed. The device (10) is arranged to display navigation directions on a display screen, to receive a video feed from a camera (24) and to display a combination of a camera image from the video feed from the camera and the navigation directions on the display. The device is a personal navigation device which includes a camera (24) integrally formed with the device and the device is arranged to provide a menu option that allows a user to adjust a relative position of the displayed camera image with respect to the navigation directions. (62) Divided Out of 564319
Patent NZ-577800-A (NZ)
Title: Method for the treatment of a material flow
Inventor: KOSCHUH WERNER
IPC: C12M1/09
Filed: 2007-12-19
Abstract: Provided is a process for the treatment of a stream of substances which contains at least one valuable substance from each of the following groups: (A) amino acids, (B) carboxylic acids different from amino acids and comprising from 1 to 5 C atoms, and (C) inorganic salts, which process comprises the steps of: (1) treating the stream of substances by nanofiltration and obtaining a retentate enriched with valuable substance (A), (2) treating the permeate of step (1) by a first electrodialysis and obtaining a concentrate enriched with valuable substance (C), (3) treating the diluate of step (2) by (4) reverse osmosis and (5) a second electrodialysis, with the reverse osmosis step (4) and the second electrodialysis step (5) being directly or indirectly interconnected, wherein at least a portion of the retentate of step (4) is directly or indirectly supplied to step (5), and at least a portion of the diluate of step (5) is directly or indirectly supplied to step (4), and obtaining a concentrate enriched with valuable substance (B) in step (5).
Patent NZ-582648-A (NZ)
Title: Pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof
Inventor: KARAVAS EVANGELOS
IPC: A61K9/20
Filed: 2007-07-23
Abstract: Disclosed is a pharmaceutical composition for oral administration comprising the dihydropyridine calcium channel antagonist Lercanidipine or a pharmaceutical acceptable salt or polymorph thereof, as an active ingredient, and colloidal silicon dioxide from 5% to 25% by weight, to enhance bioavailability and/or improve solubility wherein the composition does not include both a disintegrant and a binder.
Patent NZ-584796-A (NZ)
Title: Hybrid cable comprising electrical conductor for power transmission and optical fibre for data transmission
Inventor: SALES CASALS LLUIS-RAMON
IPC: G02B6/44
Filed: 2007-10-18
Abstract: A hybrid cable (12, 13, 14) comprises a plurality of electrical conductors (15, 23, 24), at least one optical fibre unit (16, 21, 22) and an insulation jacket (18, 25, 26) surrounding the electrical conductors and the optical fibre unit. The at least one optical fibre unit (16, 21, 22) is dispersed in a number of electrical conductors (24a) which are individually non-coated copper filaments. The number of the individually non-coated copper filaments (24a) is at least 12 times the number of the optical fibre units (16, 21, 22). The diameter of the optical fibre unit is between 1 and 5 times the diameter of the individually non-coated copper filaments. A method of wiring a building using such a hybrid cable is also disclosed.
Patent NZ-588179-A (NZ)
Title: Antiviral therapeutic agents comprising fused tricyclic compounds comprising a pyrrolo[1.2-f][1,2,4]triazine moiety
Inventor: BABU YARLAGADDA S
IPC: A61K31/7052
Filed: 2009-03-05
Abstract: Disclosed are pyrrolo[2,1-f][1,2,4]triazine compounds of formula I wherein ring B is a 5, 6, 7 or 8 membered heterocyclic ring comprising one or more double bonds, and is substituted with one or more oxo, thioxo or SO2R' group, salts thereof and methods for the compounds' preparation. The compounds of formula I are useful for treating cancer and viral infections such as hepatitis B, hepatitis C (HCV), human immunodeficiency virus (HIV), Polio, Coxsackie A and B, Rhino, Echo, small pox, Ebola, and West Nile virus.
Patent NZ-588314-A (NZ)
Title: Safety line traveller allowing for multiple connections and disconnections along the length of line
Inventor: JONES KARL
IPC: A62B35/00
Filed: 2009-04-27
Abstract: A safety line traveller that moves along a flexible safety line, made of rope, wire or a strap, that is connected to a secure structure, It consists of a body with two roller pulley wheels with grooves to rest on top of the safety line, and a plurality of slots and holes that allow either a singular or multiple personnel using lanyards to clip onto the body of the safety line traveller. The traveller body also contains an open-sided channel with an occluder or locking element moving between and open and closed positions to allow secure attachment of the traveller to any point along the safety line. If a user falls or slips, they are secured by the connection line or lanyard from a safety harness to the body of the device. The sliding rolling movement of the traveller allows safer access to users.
Patent NZ-588428-A (NZ)
Title: Oral and injectable formulations of the tetracycline compound 9-[(2,2-dimethyl-propylamino)-methyl]-minocycline
Inventor: JOHNSTON SEAN
IPC: A61K31/65
Filed: 2009-03-30
Abstract: The disclosure relates to an oral formulation in tablet form, comprising 9-[(2,2-dimethyl-propyl amino)methyl]-minocycline (a tetracycline compound) or a salt thereof, a diluent, a stabilizer, a glidant, a lubricant, and a disintegrant; and an injectable formulation comprising 90-110 mg of 9-[(2,2-dimethyl-propyl amino)-methyl]-minocycline free base or a salt thereof, one or more components selected from a lyoprotectant, an anti-oxidant, and a pH adjustment compound, and a pharmaceutically acceptable carrier.
Patent NZ-592276-A (NZ)
Title: PHARMACEUTICAL DOSAGE FORMS COMPRISING POLY(epsilon-CAPROLACTONE) AND AN OPIOID
Inventor: MACHONIS MERIDITH LEE
IPC: A61K9/16
Filed: 2009-09-17
Abstract: 592276 Disclosed is a solid oral extended release pharmaceutical dosage form, comprising a melt formed multi particulate extended release matrix formulation, comprising at least one poly(epsilon-caprolactone), and at least one active agent, wherein the at least one active agent comprises an opioid analgesic. Also disclosed is the process for making the extended release dosage form and the use of the form in the manufacture of a medicament for treating pain. Further disclosed is the use of poly(epsilon-caprolactone) as matrix forming material in opioid analgesics preparations to imparting to the solid oral extended release dosage form with a resistance to milling.
Patent NZ-603147-A (NZ)
Title: An Internal Combustion Engine
Inventor: SMITH ROGER JOHN
IPC: F01B9/02
Filed: 2012-10-19
Abstract: 603147 An internal combustion engine (1) is disclosed comprising a piston (101), a crankshaft (110) and a connecting rod assembly. The connecting rod assembly comprises a piston connecting rod (102) pivotally connected at one end to the piston (101) and a crankshaft connecting rod (103) pivotally connected at one end to the piston connecting rod (102) and at another end to the crankshaft (110). The engine also comprises a slipper plate (104) between the crankshaft (110) and the piston (101) configured to direct movement of the connecting rod joint (111). The slipper plate (104) can be adjusted during use about a pivot point (106) which is positioned substantially inline between the connecting rod joint (111) and the crank shaft pivot point.
Patent NZ-606816-A (NZ)
Title: Cheese production space having spray-proof housing
Inventor: BIGGEL ANDREAS
IPC: F16M1/00
Filed: 2011-07-21
Abstract: A device for producing processed cheese portions, comprising a plurality of modules that are arranged successively in the direction of production, in which the processed cheese is formed into a band, cooled, and divided into portions, wherein the modules define a production space through which the processed cheese travels during the production of the processed cheese portions. The production space is enclosed by a spray-proof casing, wherein the casing comprises a frame structure (1, 2, 3) and a plurality of sheet metal elements (4, 5) which are detachably connected to the frame structure. A tubular seal is arranged between a sheet metal element and the area of the frame structure opposite thereto, and encircles the sheet metal element or the area of the frame structure opposite thereto.
Patent NZ-616879-A (NZ)
Title: Fixed amount discharge container
Inventor: IIDA TAKESHI
IPC: B65D83/00
Filed: 2012-04-26
Abstract: Disclosed is an Injection syringe with a guide contacting a slope for dispensing a fixed volume to allow the easier dispensing of a fixed volume of medicament. A fixed amount discharge container (1) having a syringe barrel (3) and a piston (8) that is inserted into the syringe (3) so as to be movable in a longitudinal direction and that forms a liquid chamber with the syringe (3). Either the syringe (3) or the piston (8) is provided with a guide part (3c) that extends in the longitudinal direction thereof. The other part from between the syringe (3) and the piston (8) is provided with a slider (9) capable of moving within the guide part (3c) together with either the syringe (3) or the piston (8). The guide part (3c) is provided with a target position contact part (3j) that is contacted by the slider (9) when the liquid chamber volume becomes equal to a target volume, and the guide is provided with a slope which the slider contacts so that the slider moves along the slope.
Patent NZ-621616-A (NZ)
Title: Hydropyrolysis of biomass for producing high quality liquid fuels
Inventor: FELIX LARRY G
IPC: C10G47/02
Filed: 2010-04-05
Abstract: Disclosed herein is process for producing high quality liquid fuels from biomass in which the biomass is pyrolyzed in a reactor vessel containing molecular hydrogen and a deoxygenating catalyst, producing a partially deoxygenated hydropyrolysis liquid, which is hydrogenated using a hydroconversion catalyst, producing a substantially fully deoxygenated hydrocarbon liquid and a gaseous mixture comprising CO and light hydrocarbon gases (C1 - C3). The deoxygenation and hydroconversion are carried out to an extent whereby the liquid hydrocarbon-containing product has sufficiently low oxygen content to be phase-separable from the water-containing product.
Patent NZ-625586-A (NZ)
Title: An aqueous whey solution
Inventor: BOLDIZSAR ZOLTAN
IPC: C09K21/06
Filed: 2012-10-29
Abstract: Disclosed is an aqueous solution comprising whey, water glass (sodium or potassium silicate), polysaccharides (e.g., lactose) and a modification agent such as a surfactant (e.g., saponin). Also disclosed is the use of the aqueous solution as a flame retardant to reduce the combustibility of building and insulating materials.